Amid Medicare price negotiations for blockbuster drugs, could M&A activity heat up?


The federal government has identified 10 drugs that will be involved in the first round of Medicare price negotiations, with the aim of lowering drug costs.

Previous Birmingham doctors secure $13.9M for research study
Next Health Care Heroes: Non-Physician Providers from Christ Community, Methodist, Regional One, Saint Francis, St. Jude, UTHSC